Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


COX inhibitor
ALX-270-377-M005 5 mg 116.00 USD
ALX-270-377-M025 25 mg 363.00 USD
Do you need bulk/larger quantities?
Highly selective and potent inhibitor of cyclooxygenase-2 (IC50=10nM for COX-2 versus IC50=17.8µM for COX-1) with antitumor properties. Exhibits longer half-life time and reduced gastric toxicity in fasting rat model. Has antitumor properties and has been shown to induce apoptosis and bFGF and VEGF-driven angiogenesis. Potent antimetastatic activity against both spontaneous metastases arising following primary tumour excision and experimental metastases.

Product Specification

Alternative Name:4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
Purity:≥95% (HPLC)
Appearance:White to off-white crystalline powder.
Solubility:Soluble in DMSO.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Use/Stability:Stable for at least 2 years after receipt when stored at -20°C. Stock solutions are stable for 3 months when stored at -20°C.
Handling:Protect from light. Packaged under inert gas.
Please mouse over

Product Literature References

Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase: B.C. Wong, et al.; Gastroenterology 126, 136 (2004), Abstract;
Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway: X.H. Jiang, et al.; Oncogene 21, 6113 (2002), Abstract;
Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia: P.A. Lapchak, et al.; Stroke 32, 1220 (2001), Abstract; Full Text
Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration: D.A. Rudnick, et al.; PNAS 98, 8885 (2001), Abstract; Full Text
Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats: X. Guo, et al.; Eur. J. Pharmacol. 411, 193 (2001), Abstract;
Cyclooxygenase-2 inhibitor SC-236 attenuates mechanical allodynia following nerve root injury in rats: T.A. Deleo, et al.; J. Orthop. Res. 18, 977 (2000), Abstract;
Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia: C. Bandeira-Melo, et al.; J. Immunol. 164, 1029 (2000), Abstract; Full Text
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor: C. Petersen, et al.; Clin. Cancer Res. 6, 2513 (2000), Abstract; Full Text
Inhibition of cyclooxygenase-2 decreases DNA synthesis induced by platelet-derived growth factor in Swiss 3T3 fibroblasts: E. Castano, et al.; J. Pharmacol. Exp. Ther. 293, 509 (2000), Abstract; Full Text
COX-2 inhibitors. A new class of antiangiogenic agents: J.L. Masferrer, et al.; Ann. NY Acad. Sci. 889, 84 (1999), Abstract;
Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta: P.O. Tran, et al.; J. Biol. Chem. 274, 31245 (1999), Abstract; Full Text
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib): T.D. Penning, et al.; J. Med. Chem. 40, 1347 (1997), Abstract;
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors: J.K. Gierse, et al.; J. Biol. Chem. 271, 15810 (1996), Abstract; Full Text

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2020 Enzo Life Sciences, Inc.,